A retrospective study on the management of patients with rituximab refractory follicular lymphoma

E-ISSN： 1365-2141|180|2|217-223

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.180, Iss.2, 2018-01, pp. : 217-223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3662-3671

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Multicenter Phase II Study of Twice-Weekly Bortezomib plus Rituximab in Patients with Relapsed Follicular Lymphoma: Long-Term Follow-Up

Acta Haematologica, Vol. 137, Iss. 1, 2016-11 ,pp. : 7-14

Karger

Access to resources Recommend Favorite

Retreatment with rituximab offers a similar survival benefit as maintenance therapy in patients with low tumor burden follicular lymphoma

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 1, 2015-01 ,pp. : 1-2

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 824-834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prolonged Remission in a Patient with Relapsed Follicular Lymphoma after a Single Course of Rituximab

Oncology Research and Treatment, Vol. 29, Iss. 3, 2006-03 ,pp. : 90-92

Karger

Access to resources Recommend Favorite